Endochin-like quinolones are highly efficacious against acute and latent experimental toxoplasmosis (Q24630917)

13

0 references

Susan A. Charman

object named as

Susan A Charman

8

0 references

Jeremy Burrows

11

object named as

Jeremy N Burrows

0 references

author name string

J Stone Doggett

1

0 references

Aaron Nilsen

2

0 references

Isaac Forquer

3

0 references

Keith W Wegmann

4

0 references

Lorraine Jones-Brando

5

0 references

Robert H Yolken

6

0 references

Claudia Bordón

7

0 references

Kasiram Katneni

9

0 references

Tracey Schultz

10

0 references

David J Hinrichs

12

0 references

Michael K Riscoe

Proceedings of the National Academy of Sciences of the United States of America

15

0 references

language of work or name

English

0 references

publication date

25 September 2012

0 references

published in

0 references

volume

109

0 references

page(s)

15936-41

0 references

issue

39

0 references

cites work

Efficacy of atovaquone combined with clindamycin against murine infection with a cystogenic (Me49) strain of Toxoplasma gondii

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3465437

Remarkable in vitro and in vivo activities of the hydroxynaphthoquinone 566C80 against tachyzoites and tissue cysts of Toxoplasma gondii

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3465437

In vitro and in vivo activities of the hydroxynaphthoquinone 566C80 against the cyst form of Toxoplasma gondii

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3465437

Optimization of endochin-like quinolones for antimalarial activity

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3465437

Ocular toxoplasmosis in the developing world.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3465437

In vitro and in vivo activities of 1-hydroxy-2-alkyl-4(1H)quinolone derivatives against Toxoplasma gondii

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3465437

The history of Toxoplasma gondii--the first 100 years

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3465437

Antimalarial quinolones: synthesis, potency, and mechanistic studies

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3465437

Toxoplasma gondii infection in the United States, 1999 2004, decline from the prior decade.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3465437

Modeling the molecular basis of atovaquone resistance in parasites and pathogenic fungi

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3465437

Recapitulation in Saccharomyces cerevisiae of cytochrome b mutations conferring resistance to atovaquone in Pneumocystis jiroveci

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3465437

Prediction of human clearance of twenty-nine drugs from hepatic microsomal intrinsic clearance data: An examination of in vitro half-life approach and nonspecific binding to microsomes.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3465437

Sequence polymorphisms in the Pneumocystis carinii cytochrome b gene and their association with atovaquone prophylaxis failure

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3465437

Use of Toxoplasma gondii expressing beta-galactosidase for colorimetric assessment of drug activity in vitro

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3465437

Clinical studies of atovaquone, alone or in combination with other antimalarial drugs, for treatment of acute uncomplicated malaria in Thailand

27 September 2017

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3465437

27 September 2017

https://api.crossref.org/works/10.1073%2FPNAS.1208069109

Toxoplasmosis of the central nervous system in the acquired immunodeficiency syndrome

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3465437

Toxoplasma encephalitis in patients with the acquired immunodeficiency syndrome

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3465437

In vitro susceptibility of various genotypic strains of Toxoplasma gondii to pyrimethamine, sulfadiazine, and atovaquone

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3465437

Molecular basis of Toxoplasma gondii atovaquone resistance modeled in Saccharomyces cerevisiae

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3465437

Respiration and oxidative phosphorylation in the apicomplexan parasite Toxoplasma gondii

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3465437

Atovaquone for salvage treatment and suppression of toxoplasmic encephalitis in patients with AIDS. Atovaquone/Toxoplasmic Encephalitis Study Group.

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3465437

Use of rifabutin in combination with atovaquone, clindamycin, pyrimethamine, or sulfadiazine for treatment of toxoplasmic encephalitis in mice

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3465437

Toxoplasmosis in allo-SCT patients: risk factors and outcomes at a transplantation center with a low incidence.

30 May 2018

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.1208069109

Characterization of cytochrome b from Toxoplasma gondii and Q(o) domain mutations as a mechanism of atovaquone-resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.1208069109

Randomized phase II trial of atovaquone with pyrimethamine or sulfadiazine for treatment of toxoplasmic encephalitis in patients with acquired immunodeficiency syndrome: ACTG 237/ANRS 039 Study. AIDS Clinical Trials Group 237/Agence Nationale de Rec

21 January 2018

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.1208069109

Does atovaquone prolong the disease-free interval of toxoplasmic retinochoroiditis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.1208069109

Analysis of revertants from respiratory deficient mutants within the center N of cytochrome b in Saccharomyces cerevisiae.

21 January 2018

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.1208069109

Mutations in cytochrome b that affect kinetics of the electron transfer reactions at center N in the yeast cytochrome bc1 complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.1208069109

Drugs used in the treatment of schizophrenia and bipolar disorder inhibit the replication of Toxoplasma gondii

21 January 2018

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.1208069109

Physiological parameters in laboratory animals and humans

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23019377

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Characterization of mutations in the mitochondrial cytochrome b gene of Saccharomyces cerevisiae affecting the quinone reductase site (QN)

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23019377

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

The effect of endochin on experimental toxoplasmosis

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23019377

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1073/PNAS.1208069109

1 reference

90421

ADS bibcode

2012PNAS..10915936D

0 references

90421

1 reference

1 reference

1 reference